Soleno Therapeutics (SLNO) Depreciation & Amortization (CF) (2013 - 2026)
Soleno Therapeutics (SLNO) reported Depreciation & Amortization (CF) of $514000.0 for Q1 2026, up 1.98% year-over-year from $504000.0 in Q1 2025, and up 0.98% on a QoQ basis from $509000.0 in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $514000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 1.98% year-over-year to $514000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 1.3% YoY) and the FY2025 annual result came in at $2.0 million, up 1.51% from the prior year.
- Depreciation & Amortization (CF) climbed to $514000.0 in Q1 2026 per SLNO's latest filing, from $509000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $514000.0 in Q1 2026 and bottomed at $488000.0 in Q4 2022.
- The 5-year median for Depreciation & Amortization (CF) is $492000.0 (2022), against an average of $496470.6.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) dropped 0.81%; it then rose 2.86% in 2024.
- Tracing SLNO's Depreciation & Amortization (CF) over 5 years: stood at $488000.0 in 2022, then advanced by 0.2% to $489000.0 in 2023, then increased by 2.86% to $503000.0 in 2024, then advanced by 1.19% to $509000.0 in 2025, then increased by 0.98% to $514000.0 in 2026.
- Per Business Quant, the three latest SLNO Depreciation & Amortization (CF) figures stand at $514000.0 (Q1 2026), $509000.0 (Q4 2025), and $502000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 514,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 514,000.00 |
| Mar 31, 2026 | 514,000.00 |
| Dec 31, 2025 | 509,000.00 |
| Dec 31, 2025 | 509,000.00 |
| Sep 30, 2025 | 502,000.00 |
| Sep 30, 2025 | 502,000.00 |
| Jun 30, 2025 | 502,000.00 |
| Jun 30, 2025 | 502,000.00 |
| Mar 31, 2025 | 504,000.00 |
| Mar 31, 2025 | 504,000.00 |
| Dec 31, 2024 | 503,000.00 |
| Dec 31, 2024 | 503,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 494,000.00 |
| Jun 30, 2024 | 494,000.00 |
| Mar 31, 2024 | 490,000.00 |
| Mar 31, 2024 | 490,000.00 |
| Dec 31, 2023 | 489,000.00 |
| Dec 31, 2023 | 489,000.00 |
| Sep 30, 2023 | 490,000.00 |
| Sep 30, 2023 | 490,000.00 |
| Jun 30, 2023 | 489,000.00 |
| Jun 30, 2023 | 489,000.00 |
| Mar 31, 2023 | 490,000.00 |
| Mar 31, 2023 | 490,000.00 |
| Dec 31, 2022 | 488,000.00 |
| Dec 31, 2022 | 488,000.00 |
| Sep 30, 2022 | 492,000.00 |
| Sep 30, 2022 | 492,000.00 |
| Jun 30, 2022 | 492,000.00 |
| Jun 30, 2022 | 492,000.00 |
| Mar 31, 2022 | 492,000.00 |
| Mar 31, 2022 | 492,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Sep 30, 2021 | 492,000.00 |
| Sep 30, 2021 | 492,000.00 |
| Jun 30, 2021 | 490,000.00 |
| Jun 30, 2021 | 490,000.00 |
| Mar 31, 2021 | 489,000.00 |
| Mar 31, 2021 | 489,000.00 |
| Dec 31, 2020 | 488,000.00 |
| Dec 31, 2020 | 488,000.00 |
| Sep 30, 2020 | 489,000.00 |
| Sep 30, 2020 | 489,000.00 |
| Jun 30, 2020 | 488,000.00 |
| Jun 30, 2020 | 488,000.00 |
| Mar 31, 2020 | 489,000.00 |
| Mar 31, 2020 | 489,000.00 |
| Dec 31, 2019 | 490,000.00 |
| Dec 31, 2019 | 490,000.00 |
| Sep 30, 2019 | 490,000.00 |
| Sep 30, 2019 | 490,000.00 |
| Jun 30, 2019 | 489,000.00 |
| Jun 30, 2019 | 489,000.00 |
| Mar 31, 2019 | 489,000.00 |
| Mar 31, 2019 | 489,000.00 |
| Dec 31, 2018 | 490,000.00 |
| Dec 31, 2018 | 490,000.00 |
| Sep 30, 2018 | 490,000.00 |
| Sep 30, 2018 | 490,000.00 |
| Jun 30, 2018 | 491,000.00 |
| Jun 30, 2018 | 491,000.00 |
| Mar 31, 2018 | 492,000.00 |
| Mar 31, 2018 | 492,000.00 |
| Dec 31, 2017 | 582,000.00 |
| Dec 31, 2017 | 582,000.00 |
| Sep 30, 2017 | 459,000.00 |
| Sep 30, 2017 | 459,000.00 |
| Jun 30, 2017 | 451,000.00 |
| Jun 30, 2017 | 451,000.00 |
| Mar 31, 2017 | 119,000.00 |
| Mar 31, 2017 | 119,000.00 |
| Dec 31, 2016 | 17,670.00 |
| Dec 31, 2016 | 17,670.00 |
| Sep 30, 2016 | -44,000.00 |
| Sep 30, 2016 | -44,000.00 |
| Jun 30, 2016 | 25,000.00 |
| Jun 30, 2016 | 25,000.00 |
| Mar 31, 2016 | 20,000.00 |
| Mar 31, 2016 | 20,000.00 |
| Dec 31, 2015 | 49,228.00 |
| Dec 31, 2015 | 49,228.00 |
| Sep 30, 2015 | 28,000.00 |
| Sep 30, 2015 | 28,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Mar 31, 2015 | 15,000.00 |
| Mar 31, 2015 | 15,000.00 |
| Dec 31, 2014 | 8,516.00 |
| Dec 31, 2014 | 8,516.00 |
| Sep 30, 2014 | 6,000.00 |
| Sep 30, 2014 | 6,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 7,000.00 |
| Mar 31, 2014 | 7,000.00 |
| Dec 31, 2013 | 10,114.00 |
| Dec 31, 2013 | 10,114.00 |